Eupraxia PharmaceuticalsEPRX
那斯達克 · USD
7.46
-0.11
(-1.45%)
收盤 10/10 03:59 (UTC+8)
盤後
7.59
+0.13
(+1.74%)
10/10 03:59 (UTC+8)
Eupraxia PharmaceuticalsEPRX
7.46
-0.11
(-1.45%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 18,103 | 15,957 | 16,163 | 6,883 | 8,264 | 7,124 | 7,482 | 6,273 | 6,555 | 6,693 |
研發費用 | 12,805 | 11,174 | 7,867 | 4,418 | 5,197 | 3,850 | 3,882 | 4,050 | 3,972 | 4,175 |
推銷及管理費用 | 5,298 | 4,783 | 8,295 | 2,465 | 3,067 | 3,274 | 3,600 | 2,223 | 2,583 | 2,518 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -18,103 | -15,957 | -16,163 | -6,883 | -8,264 | -7,124 | -7,482 | -6,273 | -6,555 | -6,693 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | - | - | - | - | - | - | - | - | 282 | 321 |
稅前純益 | -14,463 | -12,641 | -16,710 | -6,370 | -8,742 | -6,764 | -7,531 | -5,991 | -6,069 | -6,152 |
所得稅 | 30 | 14 | 11 | -1 | 6 | 3 | - | - | -5 | 5 |
稅後純益 | -14,487 | -12,653 | -16,711 | -6,361 | -8,741 | -6,763 | -7,509 | -5,943 | -6,007 | -6,043 |
基本每股稅後盈餘(元) | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 | -0.21 | - | -0.17 | -0.17 | -0.21 |
稀釋每股稅後盈餘(元) | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 | -0.21 | - | -0.17 | -0.17 | -0.21 |
基本平均股數(千股) | 66221.00 | 56712.00 | 51311.00 | 36915.00 | 35912.00 | 35686.00 | - | 35622.00 | 35622.00 | 28812.00 |
稀釋平均股數(千股) | 66221.00 | 56712.00 | 51311.00 | 36915.00 | 35912.00 | 35686.00 | - | 35622.00 | 35622.00 | 28812.00 |
還原基本每股稅後盈餘(元) | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 | -0.21 | - | -0.17 | -0.17 | -0.21 |
還原稀釋每股稅後盈餘(元) | -0.23 | -0.23 | -0.37 | -0.19 | -0.26 | -0.21 | - | -0.17 | -0.17 | -0.21 |
還原基本平均股數(千股) | 66,221 | 56,712 | 51,311 | 36,915 | 35,912 | 35,686 | - | 35,622 | 35,622 | 28,812 |
還原稀釋平均股數(千股) | 66,221 | 56,712 | 51,311 | 36,915 | 35,912 | 35,686 | - | 35,622 | 35,622 | 28,812 |
EBITDA(千元) | -14,322 | -12,549 | -16,627 | -6,299 | -8,680 | -6,714 | -7,454 | -5,905 | -5,688 | -5,680 |